KMTS (KMTS) reported SG&A of $42.7M in Q4 2025.

How has KMTS's SG&A changed year-over-year?

KMTS's SG&A increased by 79.4% year-over-year, from $23.8M to $42.7M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

KMTS KMTS SG&A

SG&A at other companies

AbbottABT

$3.74B+22.2%

Boston ScientificBSX

$1.78B+11.5%

MedtronicMDT

$3.06B+12.4%

iRhythm Holdings, Inc. IRTC

$135.88M+13.3%

Merit Medical SystemsMMSI

$118.21M+10.0%

HaemoneticsHAE

$120.93M+5.0%

Other financials

Income statement

See full

Revenue$24.6M+62.7%

Gross profit$12.9M+97.1%

Operating income-$34.8M-68.8%

Net income-$34.2M-58.8%

EPS (diluted)-$0.61+51.2%

Balance sheet

See full

Cash & equivalents$291.3M+436%

Total debt$43.8M—

Total assets$379.3M—

Cash flow

See full

Operating cash flow-$18.4M-2.1%

CapEx$9.8M+141%

Free cash flow-$28.2M-27.7%

Valuation

See full

Market cap$1.29B+70.8%

Enterprise value$1.04B—

P/S15.4×—

Profitability

See full

Gross margin48.8%+15.1pp

Operating margin-171.5%+12.9pp

Net margin-173%+0.8pp

FCF margin-142.9%-25.3pp

Returns & leverage

See full

Current ratio7.3×—

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is KMTS's SG&A?: KMTS (KMTS) reported SG&A of $42.7M in Q4 2025.
How has KMTS's SG&A changed year-over-year?: KMTS's SG&A increased by 79.4% year-over-year, from $23.8M to $42.7M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.